Abstract
Staphylococcus aureus bacteremia (SAB) is a fatal disease. We aimed to describe risk factors for long-term mortality with SAB. We analyzed data from a retrospectively collected database including 1,692 patients with SAB. We considered variables of infection and background conditions for the analysis of long-term survival. The Kaplan–Meier procedure was used for analysis of long-term survival. Variables significantly associated with mortality were analyzed using a Cox regression model. We included 1,692 patients in the analysis. Patients were followed for up to 22 years. Within one year, 62% of patients died and within 5 years 72% died. A total of 82% of patients aged 65 years and older died within 5 years. Independent predictors of long-term mortality were older age (Hazard ratio 1.029, 95% confidence interval 1.022–1.036), female gender (HR 1.302, 95% CI 1.118–1.517), pneumonia or primary/ unknown source of infection (HR 1.441, 95% CI 1.230–1.689), dementia (HR 1.234, 95% CI 1.004–1.516), higher Charlson score (HR 1.155, 95% CI 1.115–1.196), shock at onset (HR 1.776, 95% CI 1.430–2.207) and arrival to hospitalization from an institution (HR 1.319, 95% CI 1.095–1.563). Long-term survival of patients older than 65 years and of women with SAB is severely curtailed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Holland TL, Arnold C, Fowler VG Jr (2014) Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 312:1330–1341
Khatib R, Sharma M (2013) Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia. Medicine (Baltimore) 92:182–188
van Hal SJ, Jensen SO, Vaska VL et al (2012) Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev 25:362–386
Kobayashi D, Yokota K, Takahashi O et al (2014) A predictive rule for mortality of inpatients with Staphylococcus aureus bacteraemia: A classification and regression tree analysis. Eur J Intern Med 25:914–918
Paulsen J, Mehl A, Askim A et al (2015) Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996–2011: an observational study. BMC Infect Dis 15:116
Yaw LK, Robinson JO, Ho KM (2014) A comparison of long-term outcomes after methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis 14:967–975
Fatkenheuer G, Preuss M, Salzberger B et al (2004) Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 23:157–162
Hanses F, Spaeth C, Ehrenstein BP et al (2010) Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection 38:465–470
Pastagia M, Kleinman LC, Lacerda de la Cruz EG et al (2012) Predicting risk for death from MRSA bacteremia. Emerg Infect Dis 18:1072–1080
Paul M, Kariv G, Goldberg E et al (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65:2658–2665
Hidayat LK, Hsu DI, Quist R et al (2006) High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166:2138–2144
Paul M, Zemer-Wassercug N, Talker O et al (2011) Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 17:1581–1586
Haessler S, Mackenzie T, Kirkland KB (2008) Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus. J Hosp Infect 69:39–45
Ho KM, Robinson JO (2009) Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Anaesth Intensive Care 37:457–463
Lamagni TL, Potz N, Powell D et al (2011) Mortality in patients with methicillin-resistant Staphylococcus aureus bacteraemia, England 2004–2005. J Hosp Infect 77:16–20
Maor Y, Hagin M, Belausov N et al (2009) Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 199:619–624
Seybold U, Kourbatova EV, Johnson JG et al (2006) Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 42:647–656
Allard C, Carignan A, Bergevin M et al (2008) Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991–2005. Clin Microbiol Infect 14:421–428
Mansur N, Hazzan R, Paul M et al (2012) Does sex affect 30-day mortality in Staphylococcus aureus bacteremia? Gend Med 9:463–470
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The current analysis was supported in part by a grant from the Israeli Ministry of Science, Technology and Space GA 3–12075. MP and LL are members of the European Society of Clinical Microbiology and Infectious Diseases—Study Group for Infections in the Elderly (ESGIE), and they would like to thank ESGIE members for their stimulating support to write this manuscript.
Conflict of interest
All authors declare no competing interests.
Ethical approval
The study was approved by the local ethical committee.
Informed consent
No informed consent was required for this retrospective study.
Rights and permissions
About this article
Cite this article
Yahav, D., Yassin, S., Shaked, H. et al. Risk factors for long-term mortality of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 35, 785–790 (2016). https://doi.org/10.1007/s10096-016-2598-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2598-8